Cheng LuFeng,Principal Investigator
1 clinical trials · Sponsor
◉ Watch Cheng LuFeng,Principal Investigator
| Record | Firm | Date |
|---|---|---|
| Clinical Study on the Immunomodulatory Effect of Eprolidone on Patients With Chronic Heart Failure (NCT05924958) | Cheng LuFeng,Principal Investigator | 2023-09-01 |
Track Cheng LuFeng,Principal Investigator automatically
Every clearance here is in the API, with alerts when new ones post.